View Author
virus fluenza patient pandemic oseltamivir resistance neuraminidase influenza mutation zanamivir fluenza virus i 223r study treatment assay fluenza viruses netherland therapy triton infection change sample inactivation rt-pcr triton x -100 h 1n virus result h 275y detection i 223r mutation -100 animal inhibitor iv zanamivir response structure figure formalin nl /2631-r titer analysis position activity control oseltamivir resistance specimen culture susceptibility substitution transmission nl /602 neuraminidase inhibitors inoculated t-cell /602 meijer mdck cells /h virus /2631-r novel disease emergence group binding panel strain ic 50 values h 275y mutation hospital van der vries laboratory surveillance recnl t-cell responses september hemagglutination difference replication table fluenza virus infection
10 Most Recent Publications
|
Reply to Chan-Tack et al
(Article)
Fraaij, P.L.A. Vries, E. van der Osterhaus, A.D.M.E. |
2013-01-01
|
|
H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis
(Article)
Vries, E. van der Collins, P.J. Martin, S.R. Boucher, C.A.B. Skehel, J.J. Gamblin, S.J. Vachieri, S.G. Xiong, X. Liu, J. Walker, P.A. Haire, L.F. Hay, A.J. Schutten, M. Osterhaus, A.D.M.E. |
2012-09-01
|
|
The potential for multidrug-resistant influenza
(Article)
Vries, E. van der Schutten, M. Boucher, C.A.B. |
2011-12-01
|
|
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010
(Article)
Meijer, A. Jonges, M. Isken, L. Jong, A. de Donker, G.A. Kroes, A. Leenders, S. Lubben, M. van der Mascini, E. Niesters, B. Oosterheert, J.J. Osterhaus, A.D.M.E. Abbink, F. Riesmeijer, R. Riezebos-Brilman, A. Schutten, M. Sebens, F. Stelma, F.F. Swaan, C. Timen, A. Veen, A. van 't Vries, E. van der Wierik, M. te Ang, W. Koopmans, M. Beek, D.J. van der Beersma, M.F.C. Bloembergen, P. Boucher, C.A.B. Claas, E. Gageldonk-Lafeber, R. van |
2011-10-01
|
|
Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection
(Article)
Fraaij, P.L.A. Vries, E. van der Wolfhagen, M.J.H.M. Houmes, R.J. Dissel, J.T. van Fouchier, R.A.M. Kroes, A. Koopmans, M. Osterhaus, A.D.M.E. Boucher, C.A.B. Beersma, M.F.C. Riezebos-Brilman, A. Niesters, H.G.M. Eijck, A.A. van der Jong, M.D. de Reis Miranda, D. Horrevorts, A.M. Ridwan, B.U. |
2011-09-01
|
|
Multidrug resistant 2009 a/h1n1 influenza clinical isolate with a neuraminidase i223r mutation retains its virulence and transmissibility in ferrets
(Article)
Vries, E. van der Kroeze, E.J.B.V. Osterhaus, A.D.M.E. Fouchier, R.A.M. Boucher, C.A.B. Herfst, S. Stittelaar, K.J. Linster, M. Linden, A. van der Schrauwen, E.J. Leijten, L.M.E. Amerongen, G. van Schutten, M. Kuiken, T. |
2011-09-01
|
|
Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus
(Article)
Vries, E. van der Stelma, F.F. Boucher, C.A.B. |
2010-09-30
|
|
Satisfying the need for rapid diagnosis of new variant influenza A H1N1
(Article)
Vries, E. van der Schutten, M. |
2010-04-01
|
|
Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling
(Article)
Jonges, M. Liu, W.M. Vries, E. van der Jacobi, R. Pronk, I. Boog, C. Koopmans, M.P.G. Meijer, A. Soethout, E. |
2010-03-01
|
|
Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase
(Article)
Vries, E. van der Jonges, M. Fouchier, R.A.M. Osterhaus, A.D.M.E. Boucher, C.A.B. Schutten, M. Herfst, S. Maaskant, J. Linden, A. van der Guldemeester, J. Aron, G.I. Bestebroer, T.M. Koopmans, M.P.G. Meijer, A. |
2010-01-01
|
